Waveguide Interferometric Optical Biosensors for Label-free Biomolecular Detection
Waveguide interferometric optical biosensors, with their high sensitivity, label-free detection capabilities, and potential for miniaturization and integration into compact devices, hold great promise for applications in personalized medicine, enabling early diagnosis, monitoring of disease progression, and point-of-care testing
Waveguide interferometric optical biosensors are highly sensitive label-free detection platforms that utilize the interference of light waves to monitor biomolecular interactions1,3,4.These biosensors operate on the principle of interferometry, where light is split into two beams traveling through different paths—one interacts with the sample and the other serves as a reference. As light passes through the waveguide, any change in the optical properties of the sample, such as refractive index caused by molecular interactions or binding events, will alter the phase of the light1,3.
The heart of these sensors is the optical waveguide, typically made of materials like silicon or polymer, which guides the light along its path. The interaction of light with the sample results in a phase shift, which, when interfered with the reference beam, creates an interference pattern. This pattern changes depending on the presence and concentration of the target analyte in the sample.
When light is coupled into the waveguides, the binding of the analyte to the sensing waveguide causes a change in the effective refractive index, which alters the optical path length of the light propagating through the sensing arm1,3. This change in optical path length leads to a phase shift between the light in the sensing and reference arms1,3. The two light beams are then combined at the output, resulting in an interference pattern that depends on the relative phase difference between the two arms1,3. By analyzing these changes in the interference pattern, the sensor can detect and quantify various biological or chemical substances.
The most common configurations for waveguide interferometric biosensors are the Mach-Zehnder interferometer (MZI) and the Young interferometer (YI)3. In the MZI design, the interference pattern is detected using a single photodetector, while in the YI configuration, the interference pattern is observed in the far-field and analyzed using a camera or a photodetector array3.
These biosensors can achieve extremely high sensitivities, with reported refractive index resolutions down to 10^-9 refractive index units (RIU), corresponding to surface coverage changes of approximately 13 fg/mm^21. They have been used for monitoring various biomolecular interactions, such as antibody-antigen complexes, protein adsorption, and DNA hybridization1,4. They are also ideal for applications in medical diagnostics, environmental monitoring, and food safety. Their label-free detection capability offers a significant advantage by reducing the complexity and cost of assays while providing real-time monitoring of interactions.
Latest Developments in Waveguide Interferometric Optical Biosensors
Recent developments in waveguide interferometric optical biosensors include the bimodal waveguide (BiMW) interferometer, which utilizes the interference between two different waveguide modes propagating in a single waveguide channel4. This design simplifies the fabrication process and reduces the footprint of the sensor compared to traditional Mach-Zehnder interferometer (MZI) and Young interferometer (YI) configurations that require two separate waveguide channels4,7.
The BiMW interferometer operates on the interference of two waveguide modes, typically the fundamental transverse electric (TE0) and the first-order transverse magnetic (TM1) modes. The binding of the target analyte to the sensing waveguide causes a change in the effective refractive index, which alters the optical path length of the TM1 mode relative to the TE0 mode. This change in the relative phase shift between the two modes leads to a modulation of the output intensity, which can be detected using a single photodetector5,6.
Another recent development is the use of polymer materials for the fabrication of waveguide interferometric biosensors. Polymer waveguides offer advantages such as low cost, ease of fabrication, and the ability to integrate with microfluidic systems. A polymer-based MZI biosensor utilizing the spectral splitting effect has been investigated, where the binding of the analyte induces a shift in the interference pattern in the spectral domain7.
These latest developments have led to more compact, integrated, and cost-effective waveguide interferometric biosensors that are suitable for mass fabrication and point-of-care applications. The simplified design and single-channel configuration of the BiMW interferometer, along with the potential of polymer materials, have expanded the possibilities for practical implementation and commercialization of these highly sensitive label-free biosensing platforms5,6,7.
The potential for miniaturization and integration of waveguide interferometric biosensors into lab-on-a-chip (LOC) devices makes them promising candidates for point-of-care diagnostics in personalized medicine. The use of silicon technology allows for the production of photonic integrated circuits (PICs) that can be incorporated into these compact sensing systems15.
One key application is the detection of disease biomarkers at extremely low concentrations, enabling early diagnosis and monitoring of disease progression. For example, a bimodal waveguide (BiMW) interferometric sensor has achieved ultrasensitive detection of microRNA-10b, a biomarker for breast cancer metastasis, at attomolar (aM) concentrations15,16.
These biosensors can also be used for studying cellular responses and processes, such as the redistribution of cellular contents, which is important for understanding disease mechanisms and developing targeted therapies. The resonant waveguide grating (RWG) technique, which combines evanescent field sensing and optical phase difference measurement, has been applied in this area16.
Furthermore, waveguide interferometric biosensors have been used for detecting and characterizing viruses, such as the avian influenza virus. By studying the binding of viruses to specific glycans, these biosensors can provide insights into viral receptor profiles, which is crucial for developing antiviral therapies and vaccines14,16.
Challenges and Limitations
One of the main challenges of waveguide interferometric optical biosensors is achieving high stability in the light coupling, which is crucial for the practical implementation of Mach-Zehnder interferometer (MZI) configurations. The Young interferometer (YI) design is more reliable and easier to use, as it is almost independent on the light intensity, but it requires more complex read-out and manipulation8,10.
Another limitation is the need for two separate waveguide channels in traditional MZI and YI configurations, which increases the footprint and complexity of the sensor. The development of bimodal waveguide (BiMW) interferometers, which utilize a single waveguide channel, has helped to address this issue by simplifying the design and fabrication process10,11.
Polymer materials have been explored as an alternative to traditional waveguide materials, offering advantages such as low cost and ease of fabrication. However, the performance and stability of polymer-based waveguide interferometric biosensors may not yet match those of their inorganic counterparts11.
Multiplexed detection, which allows the simultaneous monitoring of multiple targets on a single chip, is another area where further development is needed to fully exploit the potential of waveguide interferometric biosensors. Strategies for increasing the number of sensing channels and improving the specificity of the capture molecules are actively being researched8. Ongoing research is focused on improving surface biofunctionalization, enhancing signal-to-noise ratios, and minimizing crosstalk for multiplexed assays15,16.